New shot aims to tame BK virus in kidney transplant patients
NCT ID NCT07503561
First seen Apr 03, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This study tests whether a new drug, AIC263029, is safe and can lower BK virus levels in adult kidney transplant recipients. Participants will receive weekly injections for 4 weeks and be monitored for about 6 months. The goal is to control the virus, not cure it, as transplant patients need lifelong care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BK VIRUS INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.